Age
Visit Number vs Inhibition Naming Combined Scaled Score
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 447 | 8.7 | ± 3.6 | 9.0 | 1.0 | 17.0 | 17 | 464 |
Follow-up | 399 | 9.1 | ± 3.7 | 9.0 | 1.0 | 19.0 | 54 | 453 |
Treatment Arm vs Inhibition Naming Combined Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 447 | 8.7 | ± 3.6 | 9.0 | 1.0 | 17.0 | 6 | 453 |
Early adenotonsillectomy | 222 | 8.8 | ± 3.5 | 9.0 | 1.0 | 17.0 | 4 | 226 |
Watchful waiting | 225 | 8.6 | ± 3.6 | 8.0 | 1.0 | 17.0 | 2 | 227 |
Treatment Arm vs Inhibition Naming Combined Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 399 | 9.1 | ± 3.7 | 9.0 | 1.0 | 19.0 | 54 | 453 |
Early adenotonsillectomy | 196 | 9.3 | ± 3.7 | 9.0 | 1.0 | 19.0 | 30 | 226 |
Watchful waiting | 203 | 8.9 | ± 3.7 | 9.0 | 1.0 | 17.0 | 24 | 227 |
Age vs Inhibition Naming Combined Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 447 | 8.7 | ± 3.6 | 9.0 | 1.0 | 17.0 | 6 | 453 |
5-7 yrs old | 323 | 8.6 | ± 3.6 | 9.0 | 1.0 | 17.0 | 6 | 329 |
8-10 yrs old | 124 | 8.9 | ± 3.5 | 9.0 | 1.0 | 17.0 | - | 124 |
Age vs Inhibition Naming Combined Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 398 | 9.1 | ± 3.7 | 9.0 | 1.0 | 19.0 | 1 | 399 |
5-7 yrs old | 261 | 9.4 | ± 3.7 | 9.0 | 1.0 | 19.0 | 1 | 262 |
8-10 yrs old | 137 | 8.6 | ± 3.7 | 9.0 | 1.0 | 17.0 | - | 137 |
Gender vs Inhibition Naming Combined Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 447 | 8.7 | ± 3.6 | 9.0 | 1.0 | 17.0 | 6 | 453 |
Female | 232 | 9.1 | ± 3.5 | 9.0 | 1.0 | 17.0 | 2 | 234 |
Male | 215 | 8.2 | ± 3.5 | 8.0 | 1.0 | 17.0 | 4 | 219 |
Gender vs Inhibition Naming Combined Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 399 | 9.1 | ± 3.7 | 9.0 | 1.0 | 19.0 | 54 | 453 |
Female | 204 | 9.3 | ± 3.7 | 9.0 | 1.0 | 18.0 | 30 | 234 |
Male | 195 | 8.9 | ± 3.7 | 9.0 | 1.0 | 19.0 | 24 | 219 |
Race vs Inhibition Naming Combined Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 447 | 8.7 | ± 3.6 | 9.0 | 1.0 | 17.0 | 6 | 453 |
White | 155 | 9.5 | ± 3.3 | 9.0 | 2.0 | 17.0 | 1 | 156 |
Black | 245 | 8.1 | ± 3.5 | 8.0 | 1.0 | 16.0 | 4 | 249 |
Other | 47 | 9.4 | ± 4.0 | 8.0 | 2.0 | 17.0 | 1 | 48 |
Race vs Inhibition Naming Combined Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 399 | 9.1 | ± 3.7 | 9.0 | 1.0 | 19.0 | 54 | 453 |
White | 145 | 10.0 | ± 3.6 | 10.0 | 1.0 | 17.0 | 11 | 156 |
Black | 211 | 8.3 | ± 3.7 | 8.0 | 1.0 | 19.0 | 38 | 249 |
Other | 43 | 10.0 | ± 3.3 | 10.0 | 1.0 | 16.0 | 5 | 48 |